Abstract Background Cutaneous Leishmaniasis is a worldwide disease. endemic in 88 countries. that has shown an increasing incidence over the last two decades. So far. https://bursgaers.shop/product-category/planner/
Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629]
Internet 53 minutes ago ltrxrmqz9zbdh6
Web Directory Categories
Web Directory Search
New Site Listings